首页> 外文OA文献 >Carbohydrate PEGylation, an approach to improve pharmacological potency
【2h】

Carbohydrate PEGylation, an approach to improve pharmacological potency

机译:碳水化合物聚乙二醇化,一种提高药理效力的方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Conjugation with polyethylene glycol (PEG), known as PEGylation, has been widely used to improve the bioavailability of proteins and low molecular weight drugs. The covalent conjugation of PEG to the carbohydrate moiety of a protein has been mainly used to enhance the pharmacokinetic properties of the attached protein while yielding a more defined product. Thus, glycoPEGylation was successfully applied to the introduction of a PEGylated sialic acid to a preexisting or enzymatically linked glycan in a protein. Carbohydrates are now recognized as playing an important role in host–pathogen interactions in protozoal, bacterial and viral infections and are consequently candidates for chemotherapy. The short in vivo half-life of low molecular weight glycans hampered their use but methods for the covalent attachment of PEG have been less exploited. In this review, information on the preparation and application of PEG-carbohydrates, in particular multiarm PEGylation, is presented.
机译:与聚乙二醇(PEG)的结合称为PEGylation,已被广泛用于改善蛋白质和低分子量药物的生物利用度。 PEG与蛋白质的碳水化合物部分的共价缀合主要用于增强附着蛋白质的药代动力学特性,同时产生更明确的产物。因此,糖PEG化成功地用于将PEG化的唾液酸引入蛋白质中预先存在的或酶促连接的聚糖。如今,碳水化合物被认为在原生动物,细菌和病毒感染的宿主-病原体相互作用中起着重要作用,因此是化学疗法的候选者。低分子量聚糖的体内半衰期短,妨碍了它们的使用,但很少采用PEG共价连接的方法。在这篇综述中,介绍了有关PEG-碳水化合物的制备和应用,特别是多臂PEG化的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号